基本信息
浏览量:2
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
INTERESTS
cardiovascular biology
RESEARCH SUMMARY
Dr Berger's research primarily focuses on discovering novel mechanisms of heart disease, peripheral vascular disease, and stroke. He is also interested in 1) the etiology of unexplained thromboembolic (clotting) disease; 2) the clinical and cellular response to antithrombotic agents in cardiovascular disease; and 3) sex differences in the pathophysiology and treatment response of cardiovascular disease.
Dr. Berger has a particular interest in the field of platelet and hypercoagulable mechanisms of cardiovascular disease, with research interests that include: (1) the role of platelet activity in patients with different high risk vascular phenotypes, such as cardiac and peripheral atherosclerosis, aneurysmal disease, venous disease, kidney disease, and HIV; (2) regulation of platelet activity during the perioperative period; (3) the clinical and platelet response to antiplatelet and antithrombotic therapeutics; and (4) the study of personalized medicine using the platelet phenotype to guide therapeutics. Dr. Berger has set up a platelet lab to measure platelet activity using various techniques, including whole blood and platelet rich plasma aggregometry, flow cytometry, hematology analysis, and molecular biology using the platelet transcriptome. The overall goal of the lab is to use the platelet phenotype in understanding who is at risk for developing cardiovascular disease and to determine whether modification of the platelet phenotype can ultimately lower the risk of adverse cardiovascular events.
cardiovascular biology
RESEARCH SUMMARY
Dr Berger's research primarily focuses on discovering novel mechanisms of heart disease, peripheral vascular disease, and stroke. He is also interested in 1) the etiology of unexplained thromboembolic (clotting) disease; 2) the clinical and cellular response to antithrombotic agents in cardiovascular disease; and 3) sex differences in the pathophysiology and treatment response of cardiovascular disease.
Dr. Berger has a particular interest in the field of platelet and hypercoagulable mechanisms of cardiovascular disease, with research interests that include: (1) the role of platelet activity in patients with different high risk vascular phenotypes, such as cardiac and peripheral atherosclerosis, aneurysmal disease, venous disease, kidney disease, and HIV; (2) regulation of platelet activity during the perioperative period; (3) the clinical and platelet response to antiplatelet and antithrombotic therapeutics; and (4) the study of personalized medicine using the platelet phenotype to guide therapeutics. Dr. Berger has set up a platelet lab to measure platelet activity using various techniques, including whole blood and platelet rich plasma aggregometry, flow cytometry, hematology analysis, and molecular biology using the platelet transcriptome. The overall goal of the lab is to use the platelet phenotype in understanding who is at risk for developing cardiovascular disease and to determine whether modification of the platelet phenotype can ultimately lower the risk of adverse cardiovascular events.
研究兴趣
论文共 141 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Vascular Surgeryno. 6 (2024): e276-e277
Arteriosclerosis, Thrombosis, and Vascular Biologyno. Suppl_1 (2023)
Frontiers in Cardiovascular Medicine (2023): 960398
Natalia Eberhardt,Ravneet Kaur, Michael Gildea, Dayasagar Das,Letizia Amadori,Dawn Fernandez,Roza Shamailova, Swathy Sajja,Manila Jindal,Caron Rockman,Thomas Maldonado,Edward Fisher,
Journal of the American College of Cardiologyno. 8 (2023): 1871-1871
加载更多
作者统计
#Papers: 141
#Citation: 1611
H-Index: 22
G-Index: 22
Sociability: 6
Diversity: 2
Activity: 50
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn